Boxer Capital, LLC Kodiak Sciences Inc. Transaction History

Boxer Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.4 - $3.24 $840,000 - $1.94 Million	600,000 New	600,000 $1.82 Million
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $16.7 Million - $42.4 Million	-275,138 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.05 - $59.27 $4.23 Million - $5.57 Million	94,000 Added 51.89%	275,138 $16.3 Million
Q2 2020 Aug 14, 2020	BUY	$42.74 - $66.25 $1.33 Million - $2.06 Million	31,138 Added 20.76%	181,138 $9.8 Million
Q1 2020 May 15, 2020	BUY	$38.18 - $73.95 $5.73 Million - $11.1 Million	150,000 New	150,000 $7.16 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.